DEXTROSE INJECTION,

The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC CAGE 1UNB0 a delivery order under master contract SPE2DX25D9900 for one unit of Dextrose Injection identified by NSN 6505013318941 at a fixed price of $135.05, with award issued on July 14, 2026. Delivery is required by July 29, 2026, to two specified locations: freight shipment to Spangdahlem Air Base in Germany and parcel post to APO AE 09126-3865. The contract specifies FOB Destination delivery terms with the contractor responsible for all freight charges, and both inspection and acceptance occur at the destination. Quantity variance is strictly zero percent with no options or flexibility permitted. The product is linked to manufacturer CAGE code 11171 and NDC 00264-7510-20, with procurement request number 7017499616 and funding codes A01 and 6B used for accounting. No formal FAR clauses, Section K representations, Section M evaluation factors, or Section D packaging and marking specifications are documented within the contract notice. Packaging, labeling, and barcoding requirements such as MIL-STD-129 or MIL-STD-2073-1 are not explicitly referenced, though NSN and CAGE codes imply compliance with standard DoD logistics tracking. Payment responsibility, inspection authority, and acceptance processes are defined through delivery terms but no direct contracting officer, COR, or COTR details are provided. The award reflects a low-dollar pharmaceutical procurement likely processed under LPTA methodology, though this is not formally stated. The contract is linked to DLA Logistics Directives C19 and C20, and all administrative details including shipping addresses and funding codes are incorporated into the execution framework without additional attachments or supplemental documentation being referenced.